Residency · St Petersburg, FL
Sponsored by University of South Florida Morsani College of Medicine
Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: A Work Group Report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees.
The Journal of allergy and clinical immunology · 2022 · 167 citations · Jolan Walter, Mark Ballow
Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE).
American journal of respiratory and critical care medicine · 2025 · 28 citations · Mandel Sher
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough.
Lung · 2023 · 42 citations · Mandel Sher
Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study.
Lung · 2023 · 36 citations · Mandel Sher
The Efficacy and Safety of Gefapixant in a Phase 3b Trial of Patients with Recent-Onset Chronic Cough.
Lung · 2023 · 32 citations · Mandel Sher
Camlipixant in Refractory Chronic Cough: A Phase 2a, Randomized Controlled Trial (RELIEF).
American journal of respiratory and critical care medicine · 2025 · 13 citations ·
Simultaneous STING and lymphotoxin-β receptor activation induces B cell responses in tertiary lymphoid structures to potentiate antitumor immunity.
Nature immunology · 2025 · 20 citations · Jolan Walter
Patient-reported experiences with refractory or unexplained chronic cough: a qualitative analysis.
Therapeutic advances in respiratory disease · 2024 · 15 citations · Mandel Sher